A carregar...
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
BACKGROUND: Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors. Recently, AAP have also been shown to exhibit immunomodulatory properties in the central nervous system (CNS). OBJECTIVE:...
Na minha lista:
Publicado no: | Mult Scler J Exp Transl Clin |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publications
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5453410/ https://ncbi.nlm.nih.gov/pubmed/28607752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317698724 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|